WESTIN HARBOUR CASTLE- JUNE 7-8, 2018
THURSDAY JUNE 7, 2018
7:15-8:00
Registration and Continental Breakfast (Metropolitan West, Convention Centre, Second Level)
8:00-10:00
Sarcoma Fellows Tumor Board and Breakfast (Queen’s Quay, Convention Centre, Lower Level)
Morning Session: Networking and Patient Advocacy
9:00-9:45
LMS Foundation Session (Metropolitan West, Convention Centre, Second Level)
9:45-10:00
Coffee break
10:00-12:00pm
Patient Symposium (Metropolitan West, Convention Centre, Second Level)
11:00-12:00
CanSaRCC/CASC Combined Meeting (Queen’s Quay Room, Convention Centre, Lower Level)
Dr. Abha A. Gupta and Dr. Mai-Kim Gervais
–Discussing the establishment of a Canadian Sarcoma Database
12:00-1:00
Lunch and Poster Setup
1:00
Presentation of the Lucian Yaron Panov Patient Advocacy Award
Dr. Jay Wunder
1:10
Welcoming Remarks (Metropolitan West, Convention Centre, Second Level)
Dr. Rebecca Gladdy
Afternoon Session: CME Spotlight on Gynecologic Sarcomas- LMS
1:10-3:00
Session Chair- Dr. Rebecca Gladdy
1:10-1:15
Introduction: Start with touchpad questions on uterine LMS work up and management
1:15-1:30
General Gynecology – When is a fibroid something worse?
Dr. Ally Murji MD, MPH, FRCSC
Minimally Invasive Gynecology, Mount Sinai Hospital
Assistant Professor, Department of Obstetrics and Gynecology, University of Toronto
1:30-1:45
Diagnostic imaging of uterine masses – When to be concerned about sarcoma?
Dr. Tanya Chawla MRCP, FRCR, FRCPC
Assistant Professor, Department of Medical Imaging, University of Toronto
Head of CT Colonography Program, University
Health Network and Mount Sinai Hospital
1:45-2:00
Uterine Sarcoma- A Challenging Disease from Diagnosis to Management
Dr. Marcus Bernardini MD, MSc, FRCSC
Associate Professor, Department of Obstetrics and Gynecology, University of Toronto
Head, Division of Gynecologic Oncology, Princess Margaret Cancer Centre
2:00-2:20
Adjuvant RT in Gyn Sarcomas; what is the evidence?
Dr. Michael Milosevic MD, FRCPC (for)
Professor, Department of Radiation Oncology, University of Toronto
UT-DRO Vice Chair, Research
Director, STTARR Core III, University Health Network
Director of Research, Radiation Medicine Program,
Associate Director, Radiation Medicine Program, Princess Margaret Hospital/University Health Network
Dr. Elizabeth Baldini MD, MPH (against)
Associate Professor of Radiation Oncology, Harvard Medical School
Radiation Oncology Director, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute and Brigham & Women’s Hospital, Boston
2:20-2:30
CCO Gyne Onc Guidelines
Dr. Charles Catton MD, FRCPC
Professor, Department of Radiation Oncology, University of Toronto
Chair, Sarcoma Services Oversight Committee, Cancer Care Ontario
Radiation Oncologist, Department of Radiation Oncology
GU site group leader, Sarcoma site group leader, Radiation Medicine Program Princess Margaret Hospital/ University Health Network
30 min Panel Discussion, Q&A with audience and case presentations
3:00-3:30
Coffee Break
Dilemmas in Diagnostic Testing
3:30-5:00
Session Chair –Dr. Conrad Falkson
3:30-3:50
Diagnostic Imaging in Soft Tissue Tumours
Dr. Korosh Khalili MD, FRCP
Associate Professor, Department of Medical Imaging, University of Toronto
Staff Radiologist, Joint Department of Medical Imaging, University Health Network
3:50-4:10
Percutaneous Biopsy, is it safe?
Dr. David Berger-Richardson
PGY5, Division of General Surgery
University of Toronto
4:10-4:30
Surveillance Imaging- What is the Radiation Risk?
Dr. Mary-Louise Greer MBBS, FRANZCR
Assistant Professor, Department of Medical Imaging, University of Toronto
Staff Radiologist, Diagnostic Imaging, The Hospital for Sick Children
30 min Panel Discussion, Q&A with audience
5:00-5:15
Pre-Cocktail (Metropolitan West, Convention Centre, Second Level)
5:15
Introduction by Dr. Carol Swallow (Metropolitan West, Convention Centre, Second Level)
5:15-6:15
Soft Tissue Sarcomas: Where are we now?
Dr. Christopher D.M. Fletcher, MBBS, MD
Professor of Pathology, Harvard Medical School
Chief of Onco-Pathology, Dana-Farber Cancer Institute
Vice-Chair, Anatomic Pathology
Brigham and Women’s Hospital, Boston
6:15-7:00
Cocktail Hour and Posters (Metropolitan West, Convention Centre, Second Level)
Poster Judges:
Dr. Cindy Boulanger-Gobeil, MD FRCSC
Surgical Oncologist, CHU de Québec, Hôtel-Dieu de Québec
and
Dr. Livia Garzia, PhD
Research institute of the McGill University health center (RI-MUHC) Cancer Research Program, division of Orthopedic Surgery, McGill University
FRIDAY JUNE 8, 2018
Morning Session: Familial Sarcoma Syndromes (Metropolitan West, Convention Centre, Second Level)
8:00-10:00
Welcome and Session Chair-Dr. David Malkin
8:10-8:40
Surveillance and Sarcomas: Lessons from the “Toronto Protocol”
Dr. Anita Villani, MD, MSc
Assistant Professor, Department of Paaediatrics, University of Toronto
Associate Staff Oncologist, Haematology/Oncology, The Hospital for Sick Children
Associate Director, SickKids Cancer Sequencing Program (KiCS)
Garron Family Cancer Centre
8:40-9:10
New Insights into the Genomics of Sarcomas: from KiCS to PROFYLE
Dr. Adam Shlien, PhD
Associate Director, Translational Genetics and Genome Diagnostics, The Hospital for Sick Children
Scientist, Genetics and Genome Biology, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children
Assistant Professor, Laboratory Medicine & Pathobiology, University of Toronto
9:10-9:25
Counseling for Childhood Sarcoma
Bailey Gallinger, MSc, CGC
Genetics Counsellor, Cancer Genetics Program, The Hospital for Sick Children
Lecturer, Department of Molecular Genetics, University of Toronto
9:25-9:40
Counseling for Adult Sarcoma
Jeanna McCuaig, MSc, CGC
Genetics Counsellor, Familial Breast & Ovarian Cancer Clinic, Princess Margaret Cancer Centre
20 min Panel Discussion, Q&A with audience
10:00-10:30
Coffee break
GIST
10:30-12:00
Session Chair- Dr. Albiruni Razak
10:30-11:00
Recent developments in the pathologic assessment of GIST
Dr. Markku Miettinen, MD
Head of Surgical Pathology, Laboratory of Pathology
Center for Cancer Research, NCI/NIH, Bethesda
11:00-11:30
Molecular/clinical decision-making
Dr. Chandrajit P. Raut, MD, MSc
Associate Professor of Surgery, Harvard Medical School
Director, Surgical Oncology, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Associate Surgeon, General and Gastrointestinal Surgery
Brigham & Women’s Hospital, Boston
30 min Panel Discussion, Q&A with audience and case presentations
12:00-1:00
Lunch
1:00-2:00
Tumor Board Panel
Tumor Board Facilitator: Dr. Carol Swallow
Tumor Board Faculty: Dr. Chandrajit Raut, Dr. Markku Miettinen, Dr. Axel Le Cesne, Dr. Jay Wunder, Dr. Elizabeth Baldini, and Dr. Marcelo Cypel
Afternoon Session: Adjunctive Therapy
2:00-3:30
Session Chair-Dr. Thierry Alcindor
2:00-2:15
Outcome after Local Recurrence in High-Grade Soft Tissue Sarcomas of the Extremities; an international multicentre study
Dr. Veroniek van Praag, MD
Founder of the PERSARC study group
Leiden University Medical Centre, Leiden, The Netherlands
2:15-3:00
Current status of perioperative systemic therapy for soft tissue sarcoma
Dr. Axel Le Cesne, MD
Head, Hérault Medical Oncology Unit
Chairman, Sarcoma and Mesenchymal Tumour Committee
Institut Gustave Roussy, Villejuif, France
3:00-3:30
Radiation for RP Sarcoma
Dr. Elizabeth Baldini MD, MPH
Associate Professor of Radiation Oncology, Harvard Medical School
Radiation Oncology Director, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute and Brigham & Women’s Hospital, Boston
3:30-4:00
Coffee Break
Hot topics in Sarcoma
4:00-5:30
Session Chair: Dr. Livia Garzia
4:00-4:30
ctDNA
Dr. Trevor Pugh, PhD, FACMG
Scientist, Princess Margaret Cancer Centre
Assistant Professor, Department of Medical Biophysics, University of Toronto
Co-Director, Translational Genomics Laboratory, Ontario Institute for Cancer Research
Scientific Director, Princess Margaret Genomics Centre
4:30-5:00
Immunotherapy: Importance of the tumor microenvironment in sarcoma
Dr. Irene Andrulis, PhD
Professor, Molecular Genetics, University of Toronto
Senior Investigator, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
5:00-5:30
Epigenetic Regulation of Sarcoma
Dr. Jack Shern, MD
Assistant Clinical Investigator
Pediatric Oncology Branch
National Cancer Institute, Bethesda
5:30-6:00
Closing Remarks
Dr. Peter Ferguson, Program Head University of Toronto Sarcoma Program
